Health Care & Life Sciences » Pharmaceuticals | Reyon Pharmaceutical Co. Ltd.

Reyon Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
109,693
112,112
114,507
121,847
126,253
122,990
Cost of Goods Sold (COGS) incl. D&A
45,936
48,440
47,228
51,336
53,673
54,644
Gross Income
63,757
63,672
67,279
70,512
72,580
68,347
SG&A Expense
45,856
46,497
46,971
54,507
55,186
65,245
EBIT
17,431
16,723
19,837
15,473
16,690
2,460
Unusual Expense
-
1,356
-
-
-
-
Non Operating Income/Expense
644
1,710
322
1,092
358
3,047
Interest Expense
52
22
-
-
296
537
Pretax Income
18,269
15,092
20,614
15,143
17,045
849
Income Tax
6,976
3,499
9,276
3,351
3,620
493
Consolidated Net Income
11,293
11,593
11,338
11,792
13,424
1,341
Net Income
11,293
11,593
11,338
11,792
13,424
1,343
Net Income After Extraordinaries
11,293
11,593
11,338
11,792
13,424
1,343
Net Income Available to Common
11,293
11,593
11,338
11,792
13,424
1,343
EPS (Basic)
673.08
691.54
676.15
703.08
801.00
81
Basic Shares Outstanding
17
17
17
17
17
17
EPS (Diluted)
673.40
691.31
676.08
703.16
786.30
80.60
Diluted Shares Outstanding
17
17
17
17
18
17
EBITDA
19,828
18,578
21,597
17,415
18,695
4,327
Other Operating Expense
469
452
472
531
704
642
Non-Operating Interest Income
1,533
1,457
1,099
762
1,009
2,083

About Reyon Pharmaceutical Co.

View Profile
Address
8th Floor, Cosmo Tower
Seoul SL 06176
Korea, Republic Of
Employees -
Website http://reyonpharm.co.kr
Updated 07/08/2019
REYON PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceuticla products. Its products include medicines for antibiotic, circulatory system, anti-inflammation, contrast media, and others. The Company was founded on November 25, 1984 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.